patient self-testing

patient self-testing

Monitoring laboratory results at home to guide day-to-day decisions about health care. Examples include ambulatory blood pressure monitoring, capillary glucose monitoring, and point-of-care testing of warfarin (by measuring the prothrombin time/international normalized ratio [PT/INR] levels).
References in periodicals archive ?
Patient self-testing with CoaguChek INRange sets a new standard of care by enabling HCPs to monitor patient PT/INR data, while reducing visits to the lab.
For example, Patient Self-Testing (PST) for PT/INR can cost $2,500 or more for the test device, plus $10-20 per strip/cartridge or disposable.
A growing body of evidence indicates that the new standard in high-quality management of warfarin therapy involves patient self-testing of International Normalized Ratios at home using a fingerstick blood sample and portable point-of-care device.
Do not overlook the growth of point-of-care testing, which includes patient self-testing and home testing.
This good performance by patient self-testing of their international normalized ratio (INR) suggests that "home self-testing is an acceptable alternative to high-quality clinic care and may be preferable when patient access [to a clinic] is difficult," Dr.
Roche Diagnostics stated that the acquisition will allow it to expand its immunochemistry business from human diagnostics into life science research and development, patient self-testing, veterinary testing, drug discovery, drug development and clinical trials.
Avocet Medical received prior FDA clearances for the AvoSure(TM) PT Pro+ for healthcare professional point-of-care use and the AvoSure(TM) PT for patient self-testing.
Results come just one month after the American College of Chest Physicians (ACCP), which establishes treatment practices and standards of care, released clinical evidence in support of patient self-testing over usual outpatient INR monitoring (ACCP, 2012, p.
announced today that CoaguChek XS Personal (specially controlled medical device/medical equipment requiring specialist maintenance and management), a coagulation analyzer for patient self-testing approved in Japan on July 27, 2012, has received reimbursement approval from Japan s Ministry of Health, Labor and Welfare for use in the self-testing of patients fitted with a Nonpulsatile Left Ventricular Assist System (LVAS) and will be launched in Japan on September 25.
Point-of-care Prothrombin Time measurement for professional and patient self-testing use.
Full browser ?